Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

RSS icon
physician artificial intelligence

5 tips on AI adoption from a frontline physician champion

AI adoption for real-world healthcare settings can’t happen in a vacuum. 

burnout boreout

‘Boreout’ in the C-suite

Feeling overwhelmed by your work? There’s a lot of that going around these days. Some call it burnout. But there’s another side to the story.

quotation marks

This week in the Change Healthcare hack fallout: 10 notable quotes

“ALPHV/BlackCat and their affiliates haven’t attacked Change Healthcare. This time, they’ve attacked our families.”

artificial intelligence gold rush

Healthcare AI: Welcome to our generation’s ‘great Gold Rush’

It’s more critical for U.S. healthcare to get medical AI right than to get it adopted far, wide and ASAP.

healthcare CFOs operating margins

Pandemic-era struggles fading from relevance, healthcare CFOs optimistic about the fiscal future

December 2023 brought the 10th consecutive month with balance sheets in the black—and most healthcare financial leaders believe the momentum will have some legs.

returns on investment in healthcare artificial intelligence

When big returns on AI investment arrive in healthcare, providers will lag behind suppliers in marking the moment: Moody’s

Years will pass before the global economy’s healthcare sector sufficiently leverages AI to build major financial muscle off of it. And even then, industry players are likely to see gains well ahead of hospitals and health systems. 

mark cuban pharmacy benefits managers

Mark Cuban to CEOs: ‘If you’re using a Big 3 pharmacy benefits manager, you are getting ripped off. Period. End of story.’

The White House held a roundtable discussion on lowering healthcare costs last week. Fortune magazine followed up with one of the panelists, business mogul and Cost Plus Drugs cofounder Mark Cuban.

hospital price transparency

Transparency report called ‘irresponsible,’ ‘reckless’

Have hospitals really taken a step backward along their march toward price transparency? Or is the watchdog outfit making the claim playing fast and loose with the facts?

Displaying 297 - 304 of 467

Around the web

Cardiovascular Business
Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

Cardiovascular Business
AMA House of Delegates helps cardiology groups influence healthcare policies

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.

Cardiovascular Business
Smaller revenues, less growth: In US, tariffs may create headaches for $34.5B cardiovascular device market

“Without a more concrete and stable policy on these tariffs from the current American administration, it is likely that most manufacturers will be forced to continuously change their internal forecasts and production plans," one analyst said.